A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(2R)BSC698.
Inferred to overlap with: Df(2R)BSC769.
he presence of P+PBac{XP5.WH5}BSC777 was verified using the PCR methods and primers described in FBrf0175003.
The Gene Disruption project determined the insertion site of the progenitor P{XP}d07949 to be Release 3 genomic coordinate 18487680 on arm 2R. This corresponds to Release 5 coordinate 2R:19331635 . The insertion site of the progenitor PBac{WH}f04393 is Release 5 genomic coordinate 18997609 on arm 2R. Consequently, the molecular breakpoints of Df(2R)BSC777 predicted from the Release 5 genomic coordinates of the transposable element insertion sites are 2R:18997609 ;19331635 and the cytological breakpoints predicted from these coordinates are 59C4;59E1.